CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Common Shares	Additional Paid-in Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024		158,009,541
Beginning balance at Dec. 31, 2024	$ 27,087	$ 1	$ 328,655	$ (301,569)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	187		187
Net loss	(6,212)			(6,212)
Ending balance (in shares) at Mar. 31, 2025		158,009,541
Ending balance at Mar. 31, 2025	$ 21,062	$ 1	328,842	(307,781)
Beginning balance (in shares) at Dec. 31, 2025	159,420,141	159,420,141
Beginning balance at Dec. 31, 2025	$ (2,039)	$ 1	329,270	(331,310)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common shares issued upon vesting of restricted share units, net of withholdings (in shares)		263,812
Common shares issued upon vesting of restricted share units, net of withholding	(41)		(41)
Share-based compensation	151		151
Net loss	$ (13,112)			(13,112)
Ending balance (in shares) at Mar. 31, 2026	159,683,953	159,683,953
Ending balance at Mar. 31, 2026	$ (15,041)	$ 1	$ 329,380	$ (344,422)